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Impaired Hepatocyte Regeneration in Toll-like
Receptor 4 Mutant Mice
GRACE L. SU, MD,*† STEWART C. WANG, MD, PhD,‡ ALIREZA AMINLARI, ‡GEORGE L. TIPOE, MD, PhD,§
LARS STEINSTRAESSER, MD,‡ and AMIN NANJI, MD,¶
Multiple lines of evidence suggest a role for endogenous lipopolysaccharides in toxin-induced liver
injury. Toll-like receptor 4 has recently been implicated as a cell surface receptor important for
lipopolysaccharide responsiveness. In these experiments, we sought to determine the role of toll-like
receptor 4 in acute liver injury by carbon tetrachloride by utilizing the naturally occurring toll-like
receptor 4 mutant and wild-type mice strains. Mice were injected with either carbon tetrachloride
or the carrier. Serum transaminase levels peaked at 24 hr after carbon tetrachloride administration
for both wild-type and mutant mice, with no significant histological difference in initial liver injury
between the two groups. However, an overall decrease in hepatocyte proliferation was found in the
mutant mice. Examination of the liver tissue revealed significant decreases in intrahepatic expressions
of proinflammatory mediators. In conclusion, our results suggest that toll-like receptor 4 is important
in the hepatic regenerative response to CCl4 liver injury via its role in modulating the inflammatory
response to hepatic injury.
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Carbon tetrachloride is a potent hepatic toxin. It is me-
tabolized in the liver by the cytochrome P450 system to
a highly reactive trichloromethyl radical that can inter-
act with cellular constituents, resulting in lipid peroxida-
tion and hepatocyte necrosis. The direct effects of carbon
tetrachloride in inducing liver injury are well recognized;
however, other factors such as the immune response may
be an important determinant of outcome to CCl4-induced
liver injury. In particular, a role for endogenous lipoolysac-
charide (LPS) as a cofactor in toxin-induced liver injury
has been postulated (1–3). In carbon tetrachloride-treated
animals, gut decontamination results in decreased liver
Manuscript received December 12, 2003; accepted March 2, 2004.
From the*Medical Serivce, Veterans Affairs Ann Arbor Health Care
Systems, and Departments of†Medicine and‡Surgery, University of
Michigan School of Medicine, Ann Arbor, Mchigan, USA,§Department
of Anatomy, University of Hong Kong, Hong Kong, and¶Department of
Pathology and Laboratory Medicine, University of Pennsylvania School
of Medicine, Philadelphia, Pennsylvania, USA.
Address for reprint requests: Grace L. Su, MD, University of Michigan
Medical Center, 1510C MSRB I, Box 0666, 1150 W Medical Center
Drive, Ann Arbor, Mchigan 48109-0666, USA; gsu@umich.edu.
injury as measured by serum transaminase levels and liver
pathology (4, 5). Induction of LPS tolerance results in de-
creased hepatotoxicity from a subsequent challenge with
CCl4 (5, 6). The addition of LPS to CCl4 results in greater
liver injury than either agent alone (7). Furthermore, treat-
ment of rats with anti-LPS antibody (E5) also significantly
decreases acute injury from carbon tetrachloride (8). In
addition to its effects on injury, LPS also plays an im-
portant role in modulating the process of liver repair and
regeneration. Studies of hepatic regeneration in germ-free
animals and LPS-resistant animals show delayed hepatic
egeneration in response to partial hepatectomy (9).
The mechanism by which LPS participates in toxin-
induced injury is not completely understood but is proba-
bly related to Kupffer cell activation and production of in-
flammatory cytokines and growth factors (10, 11), Within
the liver, Kupffer cell activation by LPS is mediated via
CD14 and toll-like receptor 4 (TLR4) (12, 13). Toll-like
receptors are a group of evolutionarily conserved type
I transmembrane proteins with leucine-rich extracellular
domains and a cytoplasmic domain similar to the IL-1
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receptor. The function of these receptors is currently be-
ing elucidated and many of these receptors have been im-
plicated as critical components of the innate immune re-
sponse (14). In particular, TLR4 is important for responses
to LPS. A naturally occurring TLR4 mutation occurs in the
C3H/HeJ mouse strain and the result of this mutation is the
well-described insensitivity to LPS in these animals (15).
Specifically, Kupffer cells require a functioning TLR4 for
normal responses to LPS (13).
In this study, we examined the role of TLR4 in toxin-
induced liver injury and hepatic regeneration by utilizing
the TLR4 mutant C3H/HeJ mouse and its TLR4 wild-type
control, the C3H/HeOuJ mouse.
METHODS
Reagents
E. coli lipopolysaccharide (LPS) (serotype 0111:B4), carbon
tetrachloride and mineral oil were obtained from Sigma Chem-
icals (St. Louis, MO).
Animal Studies
Acute Carbon Tetrachloride Model. Eight- to 12-week-
old male C3H/HeOuJ and C3H/HeJ mice were obtained from
Jackson Laboratories (Bar Harbor, ME). Two identical experi-
ments were carried out, with 36 and 60 animals, respectively.
The mice were injected intraperitoneally with a single dose of
either CCl4 (1 ml/kg diluted 1:10 with mineral oil) or mineral
oil alone. Animals were sacrificed at days 1, 2, and 3 and serum
and liver tissue were collected. There was no mortality at this
dose of carbon tetrachloride.
Endotoxemia Model. Eight- to 12-week-old male
C3H/HeOuJ and C3H/HeJ mice were injected intraperitoneally
with either LPS (25µg/mouse) or saline. Animals were
sacrificed at 90 min and serum was obtained. Experiments were
performed in accordance with National Institutes of Health
guidelines and approval was obtained from the University of
Michigan Animal Care and Use Committee.
Measurements of ALT and TNF-α
Serum ALT was measured in the clinical chemistry laboratory
at the University of Michigan Medical Center. Serum TNF-α
and IL-6 levels were measured with a sandwich ELISA using
antibodies from Pharmingen (San Diego, CA).
Histology and Immunohistochemistry
Liver tissue was formalin fixed and paraffin embedded prior
to sectioning by Histological Consultants (Alabaster, AL). Liver
sections were stained with hemotoxylin and eosin. The area of
necrosis was highlighted and the area was calculated using NIH
Image 1.61 Software (National Institutes of Health, Besthesda,
MD).
Immunohistochemistry was performed using the ABC-based
method (16) with the rabbit polyclonal anti-human Ki67 anti-
body (Vector Laboratories, Burlingame, CA). Parafin-embedded
liver tissues were deparaffinized using xylene and rehydrated
with graded ethanol solutions. To unmask the antigens on paraf-
fin sections, we used the high-temperature antigen retrieval tech-
nique (16, 17). Following this procedure the tissue sections were
blocked with normal goat serum to attenuate nonspecific bind-
ing (Vectastain Elite ABC Kit; Vector Laboratories, Burlingame,
CA) and quenched in 3% hydrogen peroxide to block endoge-
nous peroxidase. Sections were incubated in the presence of the
primary anti-ki67 antibody. Next, the tissue sections were incu-
bated with a biotin-conjugated secondary antibody (anti-Rabbit
IgG made in goat; Vector Laboratories) and then with horseradish
peroxidase-conjugated streptavidin (Vectastain Elite ABC Kit;
Vector Laboratories). The chromogen Nova Red (Vector Labo-
ratorie) was used according to manufacturer’s instructions. Sec-
tions were counterstained with hematoxylin (Vector Laborato-
ries), dehydrated with ethanol, cleared with xylene, and mounted
with Mounting Medium (Richard-Allan Scientific, Kalamazoo,
MI). One thousand hepatocytes were scored per slide and the
result was calculated as the percentage positive cells.
Real-Time Reverse Transcription Polymerase Chain
Reaction (RT-PCR)
Total RNA was isolated with the TRIzol reagent per manu-
facturer’s instructions (Invitrogen, Carlsbad, CA). Reverse tran-
scription was performed as previously described (18). To deter-
mine the relative amount of cytokine mRNA, amplification of
sample cDNA was monitored using the Smart Cycler (Cepheid,
Sunnyvale, CA) and the DNA fluorescent dye SYBR Green
(Molecular Probes, Eugene OR). Primers were designed us-












Primers were designed to span at least one intron if possible
to minimize risk of genomic amplification. The specificity of the
primers was verified using analysis of PCR product on ethidium
bromide-stained agarose gel electrophoresis as well as direct
sequencing of the PCR product. All real-time PCR runs included
a Melting Curve analysis to assure the specificity of the product
with each PCR reaction.
The validity of the semiquantitative method is confirmed by
a consistent log linear correlation ofr 2 > 0.95 between start-
ing template RNA concentration and threshold cycle. All the
values were obtained by converting the threshold cycle of the
sample to relative RNA concentration based on the calibrator
RNA (a random RNA sample generating a standard curve for
that specific amplicon). All values are expressed as the ratio of
the RNA concentration of target amplicon to the RNA concen-
tration of a housekeeping gene (GAPDH) to equalize for cDNA
concentrations between samples.
Statistical Analysis
Data were analyzed using analysis of variance and two-tail
Student’st test when the data had a normal distribution (Statview
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program; Abacus Concepts/SAS Institute, Cary, NC). Statistical
significance was assigned at aP value of<0.05. All figures are
graphed with the mean± standard error.
RESULTS
C3H/HeJ (TLR4 Mutant) Mice Are Insensitive to LPS
To confirm that the C3H/HeJ mice were LPS resis-
tant, mice were injected intraperitoneally either with LPS
(25µg/mouse in saline) or with saline alone. Ninety min-
utes after LPS injection, blood was obtained and serum
TNF-α levels were measured by ELISA. There was no de-
tectable TNF-α in either the C3H/HeOuJ or the C3H/HeJ
mice injected with saline. In the mice injected with
LPS, the wild-type C3H/HeOuJ mice had significantly
higher serum TNF-α levels compared to the TLR4 mutant
C3H/HeJ mice (6269.3± 214.6 vs. 380.7± 6.6 pg/ml),
confirming the impaired responsiveness to endotoxin in
the TLR4 mutant mice (Figure 1).
Liver Injury Was Similar in TLR4 Wild-Type and
Mutant Mice After CCl 4 Treatment
TLR4 wild-type and mutant mice were given a single
injection of either CCl4 diluted in mineral oil or mineral
oil alone. Mice injected with mineral oil had minimal ele-
vations in serum ALT levels (Figure 2). In contrast, mice
injected with CCl4 had markedly elevated ALT levels in
comparison with mineral oil controls. The ALT levels
peaked at day 1 and decreased thereafter, on days 2 and
3. There were no significant difference in the ALT levels
between the TLR4 mutant and the wild-type groups.
Fig 1. Serum TNF-α levels in C3H/HeJ (TLR4+) and C3H/OuJ
(TLR4−) mice 90 min after intraperitoneal injection of either LPS
or saline. There was no detectable TNF-α in response to saline in ei-
ther strain of animals; however, significantly more TNF-α (* P < 0.01,
TLR4+ vs. TLR4−) was detected in the C3H/HeOuJ (TLR4+; wild-
type) mice compared to the C3H/HeJ (TLR4−; mutant) mice injected
with LPS.n = 2 mice per group.
Fig 2. Serum ALT levels over time in C3H/HeOuJ (TLR4 wild-type) and
C3H/HeJ (TLR4 mutant) mice injected with either CCl4 or MO (mineral
oil control). These are the composite results from the two experiments;
n = 8 animals per group.
The TLR4 mutant mice had no discernible abnormality
of liver histology as evidenced by normal histology af-
ter mineral oil in both TLR4 mutant and wild-type mice.
After carbon tetrachloride the characteristic centrilobular
necrosis was found and was most marked on day 1, with
improvement by day 3. There were no significant differ-
ences in the amount of necrosis seen in TLR4+ and TLR4
mutant groups (Figure 3).
Effect of TLR4 on the Hepatic Regenerative Response
To assess the effect of TLR4 on hepatic regeneration
after acute liver injury, we measured hepatocyte prolifer-
ation using an antibody against Ki67. This antibody de-
tects a nuclear antigen that is present in proliferating cells
(G1, S, G2 and M) but absent in quiescent cells (G0) and
necrotic cells (19, 20). Both TLR4 wild-type and mutant
animals had little hepatocyte proliferation in response to
the vehicle control (mineral oil). In contrast, after carbon
Fig 3. Percentage necrosis of liver section using image analysis.
n = 5/group.
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Fig 4. Ki67 staining of liver tissue from TLR4 wild-type (A, C, E) and TLR4 mutant (B, D,
F) mice day 1 (A and B), day 2 (C and D), and day 3 (E and F) after carbon tetrachloride.
tetrachloride injection, marked hepatocyte proliferation
was seen in the hepatocytes surrounding the necrotic areas
(Figure 4). The greatest degree of hepatocyte proliferation
was seen on day 2 and had decreased by day 3 in both of the
CCl4-treated groups. At the peak of proliferation (day 2),
there was a tendency toward decreased proliferation in the
mutant mice that persisted on day 3 (Table 1). In particu-
lar, there was significantly less proliferation in the TLR4
mutant mice after CCl4 (P < 0.05). Thus the key con-
clusion was that TLR4 mutant mice had significantly less
hepatocyte proliferation after carbon tetrachloride.
Cytokine Experession in CCl4 Animals
Because cytokines such as IL-6, TNF-α, and IL-10 have
been implicated as important mediators of hepatic regen-
eration (21, 22), we examined the intrahepatic levels of
these cytokines by real-time polymerase chain reaction
(Table 2). For all of the cytokines examined, the highest
levels of expression were on day 1, which reflected the
p riod at which the greatest liver injury was observed.
Levels of proinflammatory cytokines decreased gradually
after day 1. There was an overall trend toward lower IL-
TABLE 1. PERCENTAGE OFHEPATOCYTESSTAINING POSITIVE FOR
KI67 AFTERCCL4 IN TLR4 WILD-TYPE AND MUTANT MICE
TLR4 wild type TLR4 mutant
Day 1 0.6± 0.3 0.7± 0.2
Day 2 39.4± 11.6 15.3± 7.0
Day 3 16.0± 4.5 0.4± 0.3*
Note. n= 3 to 5 per group per time point. *P < 0.05 TLR4 wild-
type vs. mutant mice.
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TABLE 2. INTRAHEPATIC MRNA LEVELS OF(A) IL-6, (B) TNF-α,
(C) IL-10, AND (D) COX-2 AFTERCCL4 IN TLR WILD-TYPE AND
MUTANT MICE
TLR4 wild type TLR4 mutant
A. I L-6
Day 1 8.41± 2.10 7.18± 5.57
Day 2 3.33± 1.68 0.98± 0.35
Day 3 0.24± 0.05 0.11± 0.03*
B. TNF-α
Day 1 20.25± 1.78 12.27± 6.41
Day 2 8.15± 2.00 10.02± 3.48
Day 3 6.59± 0.22 3.18± 0.69*
C. IL-10
Day 1 16.15± 3.14 9.56± 5.01
Day 2 5.37± 0.49 4.44± 1.39
Day 3 17.00± 3.36 14.45± 3.00
D. COX-2
Day 1 111.69± 40.65 36.19± 15.80
Day 2 90.55± 18.72 12.6± 5.18*
Day 3 29.13± 9.56 12.4± 3.75
Note. n= 3 to 5/group.
6 and TNF-α mRNA levels in TLR4 mutant mice, which
was significant on day 3 after CCl4 injection. The decrease
in TNF-α and IL-6 expression occurred concurrently with
a decrease in hepatic proliferation at this time period. The
pattern of IL-10 mRNA expression was different from that
seen with IL-6 and TNF-α. IL-10 mRNA levels declined
rapidly on day 2 but increased on day 3. Although no
significant differences in IL-10 mRNA levels were noted
between TLR4 wild-type and mutant mice, there was a
trend toward lower IL-10 mRNA expression in the TLR4
mutant mice (Table 2C).
We also examined the expression of cyclooxygenase 2
(COX-2) mRNA, as this inflammatory mediator has also
been found to be important in liver regeneration (23). Sim-
ilar to the observations made with the cytokines, COX-2
mRNA levels were greatest on day 1 and decreased grad-
ually thereafter. Overall, there was a trend toward lower
COX-2 mRNA levels in TLR4 mutant mice that was par-
ticularly significant on day 2 (Table 1D).
In addition to evaluating intrahepatic mRNA expres-
sion, we also examined serum levels of IL-6 and TNF-
α that reflect both hepatic and extrahepatic expressions
of these cytokines (Figure 5). Similar to what was ob-
served with intrahepatic expression of these cytokines, the
highest serum levels of IL-6 and TNF-α were noted on
day 1 and decreased thereafter, on days 2 and 3. The IL-6
serum levels reflected the IL-6 mRNA levels in the liver,
with a general trend toward lower serum levels of IL-6 in
the TLR4 mutants, which was significant on day 3 after
carbon tetrachloride. There was no difference in TNF-α
levels between the groups.
Fig 5. (A) Serum IL-6 levels and (B) serum TNF-α levels in C3H/HeOuJ
(TLR4 wild-type) and C3H/HeJ (TLR4 mutant) mice injected with either
CCl4 or mineral oil. *P < 0.05 TLR4 mutant vs. wild-type.n = 4 to
6/group.
DISCUSSION
In this study, we examined two important aspects of car-
bon tetrachloride-induced liver injury: the initial necrotic
injury and the hepatic regenerative response. We showed
that the severity of necrotic liver injury secondary to car-
bon tetrachloride administration was not affected by the
absence of a functioning TLR4 receptor. C3H/HeJ (TLR4
mutant) mice had a similar degree of liver injury with car-
bon tetrachloride compared to CeH/HeOuJ (TLR4 wild-
type) mice. Both groups of animals exhibited similar de-
grees of liver injury as assessed by both histological and
biochemical criteria. In contrast, the hepatocyte prolifera-
tive response was blunted in the TLR4 mutant mice. With
respect to the mechanisms involved in the initial liver in-
jury and considering that TLR4 is important for LPS re-
sponses, we suggest that downstream pathways that are
independent of TLR4 are important for mediating the ini-
tial liver injury under the experimental conditions used
in the present study. It is important to point out that our
results differ from previous studies using anti-LPS anti-
bodies where administration of anti-LPS antibody (E5)
reduced serum AST levels by 47% (P < 0.05) and 54%
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(P < 0.05) at 36 and 48 hr after CCI4 administration
in rats (8). These studies, however, evaluated the LPS-
mediated toxicity rather than downstream signaling path-
ways of LPS signaling.
Perhaps of greater importance is that clear differences
in carbon tetrachloride-induced liver injury can be seen
between mice and rats. An important role for TNF-α in
mediating acute liver injury secondary to carbon tetra-
chloride administration is well demonstrated in the rat.
Administration of soluble TNF receptors in the rat sig-
nificantly decreased acute hepatic injury(24). In contrast,
neutralizing antibodies to TNF-α do not ameliorate acute
liver injury in the mouse (25). However, a decrease in re-
generative response in mice is noted with TNF-α antibod-
ies (25). Similarly, TNF receptor-1 deficient mice show
a decreased regenerative response to CCI4 but exhibit no
difference in acute liver injury (26).
Our observation that the hepatocyte proliferative re-
sponse was blunted in the TLR4 mutant mice supports
a role for TLR4 in the hepatic regenerative response to
carbon tetrachloride-induced liver injury and is consistent
with previous studies on the effects of LPS on hepatic
regeneration. After partial hepatectomy, a delay in liver
regeneration is noted in C3H/HeJ mice (9) compared to
conventional mice. Similarly, a decrease in liver regener-
ation is also found in germ-free animals, suggesting that
production of LPS by endogenous bacterial flora is im-
portant in hepatic regeneration (9). The mechanism by
which this occurs is likely related to the interplay of LPS
with Kupffer cells and production of cytokines which are
critical for liver regeneration.
Importantly, our results are similar to those seen in stud-
ies in mice in which there is an absence of IL-6 or TNF-α
mediated signaling in response to acute liver injury. The
need for new hepatocytes is often triggered by the loss of
liver tissue as a consequence of liver toxicity such as is
seen with carbon tetrachloride. Current evidence suggests
that cytokines such as TNF-α and IL-6 are centrally in-
volved in the regeneration of new hepatocytes (27). Based
on results obtained in IL-6-deficient and TNF RI-deficient
animals, a model has been constructed to define the role of
TNF-α and IL-6 in liver regeneration (21, 28). After liver
injury, TNF-α is initially elevated and then activates IL-6,
most likely via NF-κB. Our results showed significantly
decreased intrahepatic expression of both IL-6 and TNF-α
in the TLR4 mutant mice on day 3 after CCI4 administra-
tion that coincided with deficient liver regeneration. Simi-
larly decreased systemic levels of IL-6 were also seen. The
functional relevance of IL-6 as a terminal mediator of liver
regeneration after toxin or other forms of liver injury has
been confirmed in several studies (28, 29). Our data sup-
port the hypothesis that TLR4 mediates liver regeneration
through its modulation of IL-6 production. Serum TNF-
α levels were not significantly different between TLR4
wild-type and mutant mice; however, this may reflects
contributions from extrahepatic sources of TNF-α after
CCl4 administration. Although most of the CCl4 is me-
tabolized in the liver, extrahepatic sites of metabolism are
recognized and can also contribute to cytokine production
as a result of local injury (30).
Another proinflammatory mediator that was signifi-
cantly decreased on day 2 was cyclooxygenase 2. COX-1
and COX-2 catalyze the first step in prostaglandin syn-
thesis. COX-1 is constitutively expressed in many tissues
and is involved in the “housekeeping” functions through
production of prostaglandins. COX-2, in contrast, is the
inducible form of COX and increased expression occurs in
response to inflammatory stimuli and growth factors (31).
Recent studies have shown that prostaglandins produced
by COX-2 are important in liver regeneration after par-
tial hepatectomy. In particular, mice deficient in COX-2
show impaired liver regeneration (23). Our results, which
demonstrated decreased mRNA levels for COX-2 at a time
point when signals for liver regeneration are crucial, sug-
gest that decreased expression of this inflammatory medi-
ator may contribute to the decreased hepatocyte prolifer-
ation seen in TLR4 mutant mice after CCl4 induced liver
injury. In fact, the overall significant decreases in the in-
flammatory mediators, IL-6, TNF-α, and COX-2, suggest
that TLR4-mediated signaling is important in modulating
liver regeneration after toxin-induced liver injury.
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